Havens Advisors LLC Exact Sciences Corp Transaction History
Havens Advisors LLC
- $38.8 Million
- Q4 2022
A detailed history of Havens Advisors LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Havens Advisors LLC holds 13,500 shares of EXAS stock, worth $890,459. This represents 1.11% of its overall portfolio holdings.
Number of Shares
13,500Holding current value
$890,459% of portfolio
1.11%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding EXAS
# of Institutions
610Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.2 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.09 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$975 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$796 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$542 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...